NCT01127997 The Effect and Mechanisms of the Second-meal Phenomenon in Type 2 Diabetic Patients Status COMPLETED Phase N/A
NCT01115205 Supervised Walking Groups as a Model to Increase Physical Activity in Type 2 Diabetes Status COMPLETED Phase NA
NCT01115088 Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults Status COMPLETED Phase NA
NCT01114438 Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner Status COMPLETED Phase NA
NCT01104701 A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension Status COMPLETED Phase PHASE2
NCT01103414 Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients Status COMPLETED Phase PHASE2
NCT01101269 Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease Status TERMINATED Phase NA
NCT01099865 High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes Status COMPLETED Phase N/A
NCT01095666 A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT01095653 A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT01093794 Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) Status COMPLETED Phase PHASE1
NCT01089569 Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine Status COMPLETED Phase NA
NCT01089205 Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions. Status COMPLETED Phase PHASE1
NCT01089192 Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions. Status COMPLETED Phase PHASE1
NCT01089179 Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions Status COMPLETED Phase PHASE1